1. Home
  2. SLNG vs ICCC Comparison

SLNG vs ICCC Comparison

Compare SLNG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$4.60

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$11.03

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
ICCC
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
93.1M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
SLNG
ICCC
Price
$4.60
$11.03
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
42.4K
31.8K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
53.85
EPS
N/A
0.21
Revenue
$68,245,000.00
$26,493,169.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
$52.05
Revenue Growth
N/A
51.64
52 Week Low
$3.21
$4.52
52 Week High
$6.36
$12.10

Technical Indicators

Market Signals
Indicator
SLNG
ICCC
Relative Strength Index (RSI) 58.48 56.95
Support Level $4.42 $5.90
Resistance Level $4.74 $12.10
Average True Range (ATR) 0.39 0.59
MACD 0.09 -0.03
Stochastic Oscillator 69.53 51.94

Price Performance

Historical Comparison
SLNG
ICCC

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: